Biotech is floundering in New York City because local institutions aren't doing enough to promote commercialization of small projects, linkurl:says a new report.;http://www.nycfuture.org/content/articles/article_view.cfm?article_id=1252&article_type=0
"The criticism," said Jonathan Bowles of the Center for an Urban Future, a New York City think tank that published the report last month, is that "for a long time [technology transfer offices] put too much emphasis on the blockbuster deal," ignoring smaller technologies that could have been developed by start-up companies with the help of venture backing. The group based its conclusions on the most recent data on science and engineering from the National Science Foundation, sources such as the Association of University Technology Managers and PricewaterhouseCoopers, and interviews with venture capitalists, tech transfer experts, and other key players in innovation in the region. There's no doubt that institutions in the New York City metro area -- that is, New York City and parts...
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?